Abstract: A composite optical film comprises: a first substrate; a plurality of reversed prisms disposed on a bottom surface of the first substrate; and a first diffusion film disposed over a top surface of the first substrate.

Abstract: Improved methods for drying for bio-compatible solid phase microextraction (BioSPME) coatings yielding coatings with highly consistent extraction efficiency and biocompatibility. The methods, adapted to flow-through drying systems involve determining relative humidity in and around the drying system, determining a drying temperature range based on the relative humidity, and maintaining the drying temperature within the determined range while drying the coating.

Abstract: Disclosed herein are compositions and methods for treating a subject having an itch-related disorder, such as dermatological disorders or systemic disorders comprising itch. The methods may include determining the level of a biomarker in a biological sample from the subject. The biomarker may be selected from TRPV4 expression, lysophosphatidylcholine, and miRNA-146a expression, or a combination thereof. The subject may be identified as having the itch-related disorder when the level of the biomarker is greater in a sample from the subject than in a control. An anti-pruritic therapy may be administered to treat the subject having the itch-related disorder.

Abstract: The present disclosure relates to a method for recycling a taurine mother liquor, which includes: adding a base to the taurine mother liquor, heating to a first temperature, carrying out a hydrolysis reaction, removing ammonia produced, and evaporating and concentrating the ammonia-removed solution to obtain an alkali metal hydroxyethyl sulfonate solution. When applying the method provided by the present disclosure for the recycling of the taurine mother liquor, the taurine mother liquor can be further converted into the alkali metal hydroxyethyl sulfonate solution, impurities are removed from the obtained alkali metal hydroxyethyl sulfonate solution, the impurity-removed alkali metal hydroxyethyl sulfonate solution is concentrated and crystallized, and the alkali metal hydroxyethyl sulfonate is separated out.

Abstract: A system for additively manufacturing a build part. The system includes a build platform configured for disposition within a resin tank, and a light source configured to cure a layer of resin. The layer of resin is disposed adjacent to a pre-cure build surface of the build part. The system also includes a constrained surface located between the build platform and the light source and configured to form a boundary for the layer of resin disposed between the constrained surface and the pre-cure build surface. The constrained surface is configured to vibrate to reduce a separation force required to separate the constrained surface from a post-cure build surface of the build part. The system also includes a vibratory source configured to vibrate the constrained surface.

Abstract: Provided are a method, an apparatus and a system for implementing carrier grade network address translation, an electronic device, and a computer-readable storage medium. The method includes: transmitting a first request to a control plane of a forwarding and control separated broadband access system, where the first request is used for applying to the control plane for a public network address range; receiving a first response returned by the control plane, where the first response includes allocated public network address range information; receiving a public network address allocated to a user by the control plane according to the public network address range information; receiving a private network address allocated to the user by the control plane; and performing, according to the public network address and the private network address, public and private network address translation on received service traffic of the user.

Abstract: Disclosed is a high-efficiency cyclic preparation method for a columnar taurine finished product, including: preparing an aqueous taurine solution with a certain concentration; introducing the aqueous taurine solution into a basic resin for treatment to remove an alkali metal isethionate and an isethionic acid derivative; monitoring an effluent liquid at an outlet of the basic resin and collecting the effluent liquid that is monitored to be qualified; and crystallizing taurine of the collected effluent liquid to obtain a taurine crystal. The method of the present disclosure has the advantages of process innovation, and high efficiency, and the obtained taurine crystal has the advantages of good quality, good fluidity, no caking, low production cost and high efficiency, and has good prospects for industrial production.

Abstract: Disclosed is an isolated or purified T cell receptor (TCR) having antigenic specificity for mutated Kirsten rat sarcoma viral oncogene homolog (KRAS) presented in the context of an HLA-Cw*0802 molecule. Related polypeptides and proteins, as well as related nucleic acids, recombinant expression vectors, host cells, populations of cells, and pharmaceutical compositions are also provided. Also disclosed are methods of detecting the presence of cancer in a mammal and methods of treating or preventing cancer in a mammal.

Abstract: Compositions and methods for the treatment of viral infections include conjugates containing inhibitors of viral neuraminidase (e.g., zanamivir, peramivir, or analogs thereof) linked to an Fc monomer, an Fc domain, and Fc-binding peptide, an albumin protein, or albumin-binding peptide. In particular, conjugates can be used in the treatment of viral infections (e.g., influenza viral infections).

Abstract: The present disclosure provides a resin composition, an adhesive-dropping material, an adhesive-pressing material, and a preparation method and application thereof. The resin composition comprises the following components: an ester-based prepolymer; a reactive diluent; and a photoinitiator; wherein the addition amount of the ester-based prepolymer is 60 to 80 parts by weight, the addition amount of the reactive diluent is 15 to 30 parts by weight, and the addition amount of the photoinitiator is 1 to 5 parts by weight, based on the part by weight. The artificial nail prepared by using the resin composition, the adhesive-dropping material, and the adhesive-pressing material according to the present disclosure has high mimicry. When in use, the artificial nail which is not completely hardened may be attached to the surface of the real nail and then hardened by UV light, so that the artificial nail is more conformable.

Abstract: Disclosed is an isolated or purified T cell receptor (TCR) having antigenic specificity for mutated Kirsten rat sarcoma viral oncogene homolog (KRAS) presented in the context of an HLA-Cw*0802 molecule. Related polypeptides and proteins, as well as related nucleic acids, recombinant expression vectors, host cells, populations of cells, and pharmaceutical compositions are also provided. Also disclosed are methods of detecting the presence of cancer in a mammal and methods of treating or preventing cancer in a mammal.

Abstract: A base assembly includes a mounting structure and a support structure. The mounting structure includes a base body, a main body, and a guide rod provided between the base body and the main body. The support structure includes a sliding element and support legs. The sliding element is slidably connected to the guide rod. Each of the support legs is provided with a rotating end and a support end that are arranged opposite to each other. The rotating end is rotatably connected to the sliding element. The sliding element is slidable toward the main body to drive a plurality of support ends to approach each other, such that the base assembly is in a folded state. One of the base body and the support leg is provided with a first locking element, and the other of the base body and the support leg is provided with a second locking element.

Abstract: Compositions and methods for the treatment of viral infections include conjugates containing inhibitors of viral neuraminidase (e.g., zanamivir, peramivir, or analogs thereof) linked to an Fc monomer, an Fc domain, and Fc-binding peptide, an albumin protein, or albumin-binding peptide. In particular, conjugates can be used in the treatment of viral infections (e.g., influenza viral infections).

Abstract: A base assembly includes a mounting structure and a support structure. The mounting structure includes a base body, a main body, and a guide rod provided between the base body and the main body. The support structure includes a sliding element and support legs. The sliding element is slidably connected to the guide rod. Each of the support legs is provided with a rotating end and a support end that are arranged opposite to each other. The rotating end is rotatably connected to the sliding element. The sliding element is slidable toward the main body to drive a plurality of support ends to approach each other, such that the base assembly is in a folded state. One of the base body and the support leg is provided with a first locking element, and the other of the base body and the support leg is provided with a second locking element.

Abstract: Provided in the embodiments of the present disclosure are a blockchain-based method and system for handling domain name abuse. All network nodes in a public blockchain can report domain name abuse, and all network nodes receiving reported data are entitled to participate in the process of judging whether domain name abuse exists in the reported data. The public blockchain obtains a target judgment result of whether domain name abuse exists by means of integrating first judgment results of multiple identification nodes on whether domain name abuse exists in the reported data and credit value of each identification node. Alternatively, when the number of identification nodes in the public blockchain is less than a preset number of nodes, a consortium blockchain composed of regulatory agencies directly judges whether domain name abuse exists in the reported data, and the judgment result serves as the target judgment result.

Abstract: The present application provides an automated system and method for improving and generating annotated magnetic resonance (MRI) images based on magnetic resonance fingerprinting (MRF) data. The present disclosure also provides an automated method for generating the automated system for improving annotated MRI images. In some aspects, the method comprises accessing MRF data, MRI data, and images annotated with bulk-pixel labels that identify a tissue class for a group of patients. The annotated images can be used to train a machine learning system based on MRF data. The system can be trained to assign pixel labels to pixels outside the bulk-pixel labels to create an automated system. The automated system provided may be used to determine disease states using MRF data and generate machine-annotated images that include labels that indicate a tissue class. In this way, the present disclosure provides an automated system and method for improving incomplete annotations.

Abstract: Embodiments of the present disclosure provide a method and apparatus for processing a message header, a storage medium, and an electronic apparatus.

Abstract: Embodiments of the present disclosure provide a network configuration sending method and apparatus, a storage medium, and an electronic device. The method includes: determining N rule-action pairs corresponding to Quality of Service (QoS) configuration information of each layer in Hierarchical Quality of Service (HQoS) configuration, wherein the N rule-action pairs are used for representing network configuration rules and network configuration actions corresponding to the QoS configuration information, and N is a natural number greater than or equal to 1; and sending, to a forwarding plane of a Broadband Remote Access System (BRAS), target QoS configuration information mapped with the N rule-action pairs, wherein the forwarding plane is used for configuring the target QoS configuration information into a target device to configure a network of the target device.